GCI

6th November 2024
07:00

Hutchmed China Ltd - Clinical Data to be Presented at ASH and ESMO Asia

31st October 2024
08:30

Hutchmed China Ltd - Total Voting Rights

31st October 2024
08:30

Hutchmed China Ltd - First Commercial Milestone Payment

21st October 2024
08:30

Hutchmed China Ltd - Vesting of awards under the LTIP

16th October 2024
06:00

Hutchmed China Ltd - SAVANNAH: clinically meaningful response rate

24th September 2024
07:00

Hutchmed China Ltd - Japan Approval for FRUZAQLA

9th September 2024
06:00

Hutchmed China Ltd - Clinical Data to be Presented at ESMO and WCLC

30th August 2024
08:30

Hutchmed China Ltd - Total Voting Rights

30th August 2024
06:00

Hutchmed China Ltd - Update on Fruquintinib for Gastric Cancer in China

22nd August 2024
08:30

Hutchmed China Ltd - Standard form for notification of major holdings

21st August 2024
08:30

Hutchmed China Ltd - HUTCHMED to Host Expert Call to discuss ITP

6th August 2024
09:00

Hutchmed China Ltd - LTIP and Share Option Scheme

31st July 2024
11:00

Hutchmed China Ltd - 2024 Interim Results and Business Updates

4th July 2024
06:00

Hutchmed China Ltd - NDA Acceptance in China for Tazemetostat

28th June 2024
11:35

Hutchmed China Ltd - Overseas Regulatory Announcement: Form F-3 Filing

28th June 2024
08:30

Hutchmed China Ltd - Total Voting Rights

28th June 2024
08:30

Hutchmed China Ltd - Blocklisting Six Monthly Return

26th June 2024
08:30

Hutchmed China Ltd - HUTCHMED to Announce 2024 HY Financial Results

HUTCHMED (China) Limited (HCM.L) Share Price & News

Bid

-

-

-

Ask

High
-
OPEN
-
VOL
-
MKT CAP
-M

LOW
-
CLOSE
-
SHARES IN ISSUE
871.04M

HUTCHMED (China) Limited Share Price Chart

Watchlist